The HZI is continuously building a network of closely aligned strategic partnerships with universities, research institutions and hospitals. Its primary objective is to create synergies which establish the optimal conditions for an efficient transfer of knowledge from basic research to medical application: HZI Locations.
Learn more about how the HZI, with its translational focus, will help to facilitate a faster and more targeted approach when it comes to fighting and preventing existing, emerging or recurring infectious diseases.
Around 900 employees in research, administration and infrastructure, and about 220 visiting scientists from 40 different countries are employed at the Helmholtz Centre for Infection Research. To ensure top quality research we need top quality employees. Your creativity and innovative capabilities are the basis for the long-term success of our work. That's why we undertake a great deal to attract the best people to us. Learn more about this.
We communicate also through social media. Join our Facebook page, follow us on Twitter or subscribe to our YouTube-Channel.
Systems BiologyThe goal of systems biology is to describe the dynamic processes of life and of biological systems using mathematical models. In line with the foundation of the new Braunschweig Integrated Centre of Systems Biology (BRICS) we have compiled some background information about systems biology for you: To the systems biology feature.
In memory of the chemist Prof. Hans Herloff Inhoffen, who died in 1992, the Helmholtz Centre for Infection Research (HZI) and the Technical University (TU) Braunschweig annually organize the Inhoffen lecture and award the Inhoffen Medal since 1994. The prize is endowed with 8000 Euros.
Results 1 to 10 of total 341
HZI researchers identify target on the viral envelope and develop customised agents
Clara Chepkirui presented with award for her work on tropical fungi
Evotec and Helmholtz Centre aim to jointly develop cystobactamid derivates into a new class of broad spectrum antibiotics targeting high-priority pathogens
Markus Cronberg succeeds Michael Manns as Clinical Director of the HZI
HZI researchers identify a tool with which a herpesvirus specifically attenuates the body's immune system
HIRI director is honoured for German-British exchange in science
Researchers from the HZI and the HIPS discovered that resistant bacteria scavenge and inactivate the agent albicidin using a protein, which they produce in large amounts
For the seventh time running, HZI has awarded its prize for junior infection researchers during the “North Regio Day on Infection” symposium (NoRDI)
HZI and InSCREENeX GmbH have been honoured by the Chamber of Industry and Commerce Braunschweig for the development of personalised cellular systems
HZI scientists establish how the cytoskeleton is regulated and manipulated